These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1019574)

  • 1. Intra-arterial infusion of prostaglandin E1 in normal subjects and patients with peripheral arterial disease.
    Nielsen PE; Nielsen SL; Holstein P; Poulsen HL; Hansen EH; Lassen NA
    Scand J Clin Lab Invest; 1976 Nov; 36(7):633-40. PubMed ID: 1019574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of intravenous PGE1 on patients with arterial occlusive disease of the leg.
    Hirai M; Nanki M; Nakayama R
    Angiology; 1985 Jul; 36(7):407-13. PubMed ID: 4040721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of intra-arterial and intravenous administration of prostaglandin E1 in patients with peripheral arterial disease.
    Hirai M; Nakayama R
    Br J Surg; 1986 Jan; 73(1):20-3. PubMed ID: 3947867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular effect of prostaglandin (PGE1) infused into the femoral artery in normals and patients with occlusive arterial disease.
    Nielsen PE; Holstein P; Nielsen SL; Poulsen HL
    Bibl Anat; 1975; 13():305-6. PubMed ID: 1231765
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of prostaglandin E1 on blood flow in normal and ischemic canine hindlimbs.
    Pasch AR; Ricotta JJ; Burke AR; O'Mara RE; DeWeese JA; Wilson G
    Surgery; 1984 Jun; 95(6):724-9. PubMed ID: 6539509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain gauge studies of distal blood pressure in normal subjects and in patients with peripheral arterial disease. Analysis of normal variation and reproducibility and comparison to intraarterial measurements.
    Nielsen PE; Bell G; Lassen NA
    Scand J Clin Lab Invest Suppl; 1973; 128():103-9. PubMed ID: 4283879
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of intravenous and intra-arterial infusions of prostaglandin E1 on canine hindlimb blood flow distribution.
    Lynch TG; Hobson RW; Barbalinardo JP; Kerr JC
    Surgery; 1984 Jul; 96(1):35-41. PubMed ID: 6539953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital blood pressure in normal subjects and patients with peripheral arterial disease.
    Nielsen PE
    Scand J Clin Lab Invest; 1976 Dec; 36(8):725-30. PubMed ID: 1031484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intravenous prostaglandin E1 on ischaemic pain and on leg blood-flow in subjects with peripheral artery disease: a double-blind controlled study.
    Jogestrand T; Olsson AG
    Clin Physiol; 1985 Dec; 5(6):495-502. PubMed ID: 3912093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical observations with intravenous prostaglandin E1 in peripheral vascular disease.
    Feldman SM; Alpert J; Dick LS; Brief DK; Goldenkranz R; Brener BJ; Parsonnet V
    J Med Soc N J; 1982 Dec; 79(13):985-7. PubMed ID: 6961223
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease.
    Creutzig A; Creutzig H; Alexander K
    Eur J Clin Invest; 1986 Dec; 16(6):480-5. PubMed ID: 3104047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous infusion of prostaglandin E1 (PGE1) in management of limb ischemia.
    Sethi GK; Bridgman AH; King L; Scott SM
    Am Surg; 1986 Sep; 52(9):474-8. PubMed ID: 3752724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of induced arterial hypertension upon regional blood flow in subcutaneous tissue in patients with arterial insufficiency of the legs.
    Henriksen O; Wisborg K
    Scand J Clin Lab Invest; 1975 Mar; 35(2):115-20. PubMed ID: 1145106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The erect posture as an aid to the circulation in the feet in the presence of arterial obstruction.
    Gaskell P; Becker W
    Can Med Assoc J; 1971 Nov; 105(9):930-4. PubMed ID: 4948517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1 in severe lower limb ischaemia: a double-blind controlled trial.
    Telles GS; Campbell WB; Wood RF; Collin J; Baird RN; Morris PJ
    Br J Surg; 1984 Jul; 71(7):506-8. PubMed ID: 6375799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
    Lowe GD; Morrice JJ; Forbes CD; Prentice CR; Fulton AJ; Barbenel JC
    Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experiences with prostaglandin E1 in severe peripheral artery disease].
    Carlson LA; Jogestrand T; Kaijser L; Olsson AG
    Lakartidningen; 1977 Aug; 74(31):2629-33. PubMed ID: 895269
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of thigh blood flow upon the arterial pressure gradient over the collateral arteries in patients with occlusion of the superficial femoral artery.
    Agerskov K
    Cardiovasc Res; 1982 Jun; 16(6):304-7. PubMed ID: 7105098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, hemodynamic and metabolic effects of intraarterial infusions of prostaglandin E1 in patients with peripheral vascular disease.
    Olsson AG; Carlson LA
    Adv Prostaglandin Thromboxane Res; 1976; 1():429-32. PubMed ID: 998436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.